Institutional investors hold a majority ownership of TECH through the 99.51% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2014, these large investors purchased a net $2.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUMMIT CREEK ADVISORS LLC Bought 70.5 Thousand shares of Bio-Techne Corp
RIVERBRIDGE PARTNERS LLC Bought 9.2 Thousand shares of Bio-Techne Corp
RICE, HALL, JAMES & ASSOCIATES L... Bought 7.9 Thousand shares of Bio-Techne Corp